Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2006 Update of an American Society of Clinical Oncology Practice Guideline
J Clin Oncol Loblaw et al 25:1596
Publisher’s Note
The April 20, 2007 ASCO special article by Loblaw et al entitled, “Initial Hormonal Management of Androgen-Sensitive Metastatic, Recurrent, or Progressive Prostate Cancer: 2006 Update of an American Society of Clinical Oncology Practice Guideline” (J Clin Oncol 25:1596-1605, 2007) was published online April 2, 2007 with errors.
In the Guidelines Recommendations section, the heading for subsection no. 4 referred to SDT, whereas it should have been ADT, as follows:
“Does Early ADT Improve Outcomes Over Deferred Therapy?”
In the title and in several instances in the text, the article referred to a 2006 update, a 2006 recommendation, or a 2006 literature update and discussion, whereas it should have been 2007 in each instance.
All corrections have been made as of August 28, 2007.
|
